🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

148,36 USD

Máx. histórico

156,45

69 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-5,17%

Rango 52 semanas

82,01 – 156,92

Variación hoy

-0,78%

Cierre anterior

149,52

Rango de hoy

147,12 – 150,25

Volumen hoy

9.050.917

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,42%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
149,86 (puede no estar actualizado)
Dividend yield
2,27% (puede no estar actualizado)
Precio objetivo analistas
159,91 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 15 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,29%
Fecha de pago Importe por participación
14/12/2022 0,7300 USD
14/09/2022 0,6900 USD
14/06/2022 0,6900 USD
14/03/2022 0,6900 USD
14/12/2021 0,6900 USD
14/09/2021 0,6500 USD
14/06/2021 0,6500 USD
12/03/2021 0,6202 USD
14/12/2020 0,6202 USD
14/09/2020 0,5821 USD
12/06/2020 0,5821 USD
13/03/2020 0,5821 USD
13/12/2019 0,5821 USD
13/09/2019 0,5248 USD
14/06/2019 0,5248 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/11/2026 148,82 150,25 147,12 148,36 -0,78% 2,11% 9.050.917
30/10/2026 149,55 151,35 147,40 149,52 +2,18% 2,64% 12.341.400
29/10/2026 144,62 149,26 143,32 146,33 +3,83% 4,11% 13.447.600
28/10/2026 140,00 142,40 139,21 140,93 -0,63% 2,28% 8.239.700
27/10/2026 140,22 142,69 139,83 141,82 +0,86% 2,04% 9.057.700
26/10/2026 145,89 146,61 139,93 140,61 -3,21% 4,58% 13.103.800
23/10/2026 145,02 145,44 143,41 145,27 -1,34% 1,40% 8.379.200
22/10/2026 151,05 154,02 144,07 147,24 -1,76% 6,59% 19.024.600
21/10/2026 147,11 150,00 147,11 149,88 +1,07% 1,96% 9.006.800
20/10/2026 146,29 149,36 146,12 148,30 +3,25% 2,21% 9.923.600
19/10/2026 145,00 147,41 143,53 143,63 -1,59% 2,68% 10.448.200
16/10/2026 146,96 147,80 145,61 145,95 +0,52% 1,49% 11.232.500
15/10/2026 149,70 152,34 144,91 145,19 -1,48% 4,96% 13.865.500
14/10/2026 143,10 148,16 142,66 147,37 +3,80% 3,84% 9.799.700
13/10/2026 145,85 145,93 141,58 141,98 -2,39% 2,98% 8.377.800
12/10/2026 145,75 146,36 144,64 145,45 -0,10% 1,18% 8.018.900
09/10/2026 141,37 146,68 141,36 145,60 +2,26% 3,76% 9.287.700
08/10/2026 141,90 142,77 138,89 142,38 -0,29% 2,73% 8.404.800
07/10/2026 142,03 144,15 141,49 142,79 +0,60% 1,87% 6.352.200
06/10/2026 140,13 142,16 139,74 141,94 +1,72% 1,73% 8.072.700
05/10/2026 143,67 144,06 138,80 139,54 -3,30% 3,66% 9.478.700
02/10/2026 143,77 144,35 142,73 144,30 +0,34% 1,13% 9.657.900
01/10/2026 144,71 145,39 143,26 143,81 -1,03% 1,47% 7.856.200
30/09/2026 148,95 149,27 145,26 145,31 -2,66% 2,69% 10.223.500
29/09/2026 148,17 150,36 146,09 149,28 +0,40% 2,88% 8.203.400
28/09/2026 147,65 149,19 146,28 148,69 -0,06% 1,97% 7.701.000
25/09/2026 148,06 149,98 147,48 148,78 +0,54% 1,69% 8.288.800
24/09/2026 148,17 151,46 147,90 147,98 -0,07% 2,40% 10.312.300
23/09/2026 151,32 152,01 146,89 148,08 -1,88% 3,38% 9.699.700
22/09/2026 148,69 153,57 148,04 150,91 +0,94% 3,72% 11.172.100